Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma
Clinical trial NCT03029234 · COMPLETED
Trial details
- NCT number
- NCT03029234
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-31
- Primary completion
- 2018-11-05
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.